title: Evidence-based guideline: Treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.
authors.affiliation: Israel.
authors.forename: Vladimir
authors.initials: V
authors.lastname: Lerner
authors.forename: Chanoch
authors.initials: C
authors.lastname: Miodownik
authors.forename: Be'er
authors.initials: B
authors.lastname: Sheva
authors.forename: Roongroj
authors.initials: R
authors.lastname: Bhidayasiri
authors.forename: Stanley
authors.initials: S
authors.lastname: Fahn
authors.forename: Gary S
authors.initials: GS
authors.lastname: Gronseth
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Sullivan
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Zesiewicz
mesh_terms: D018492:Dopamine Antagonists / Q000009:adverse effects*; D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D009069:Movement Disorders / Q000628:therapy*; D009462:Neurology / Q000592:standards*; D017410:Practice Guidelines as Topic / Q000592:standards*
chemical_list: D018492:Dopamine Antagonists